Membrane Oxygenators Market Size, Share & Forecast Analysis to 2030

The global membrane oxygenators market size was valued at around USD 0.2 billion in 2025 and projected to grow at a significant CAGR of around 3% during the forecast period from 2026 to 2030. The market is expanding due to the rising prevalence of cardiovascular and respiratory diseases and increasing demand for advanced life-support systems. Technological advancements in hollow fiber membrane oxygenators are enhancing gas exchange efficiency, biocompatibility, and patient outcomes during cardiac procedures. North America leads the market owing to its advanced healthcare infrastructure, while Asia Pacific is witnessing rapid growth driven by expanding healthcare investments and increasing adoption of extracorporeal life-support technologies.

Market Snapshot:

Key Insights:

• Hollow fiber membrane oxygenators dominate due to superior gas exchange efficiency, biocompatibility, and widespread clinical adoption.
• Cardiopulmonary bypass procedures remain the leading application, driven by increasing cardiovascular surgeries and advanced cardiac care.
• North America holds the dominant market share due to advanced healthcare infrastructure and high ECMO adoption rates.
• Technological advancements in ECMO systems and oxygenator designs are improving patient safety and treatment outcomes.

Key Drivers Fueling the Membrane Oxygenators Market Growth

The increasing prevalence of cardiovascular diseases, acute respiratory distress syndrome (ARDS), and chronic respiratory disorders is a major driver of the membrane oxygenators market. Rising volumes of cardiac surgeries and the growing adoption of extracorporeal membrane oxygenation (ECMO) in intensive care units are strengthening demand for reliable oxygenation devices that improve patient survival and support complex surgical procedures.

Technological advancements in membrane oxygenators, including improved biocompatible materials, enhanced gas exchange efficiency, and reduced blood trauma, are further accelerating market growth. In 2025, Medtronic received U.S. FDA clearance for its VitalFlow ECMO System, expanding the availability of advanced extracorporeal life-support solutions for critically ill patients and reinforcing innovation across the membrane oxygenators market.

Key Growth Drivers:

• Rising prevalence of cardiovascular diseases, respiratory failure, and critical care conditions is increasing the demand for extracorporeal life-support systems.
• Growing adoption of ECMO procedures and increasing cardiac surgeries are driving the need for efficient membrane oxygenators in hospitals and specialty care centers.
• Technological advancements in oxygenator design, including improved biocompatibility, enhanced gas exchange performance, and reduced blood trauma, are supporting wider clinical adoption.

Membrane Oxygenators Market Restraining Factors

The high cost associated with membrane oxygenators, ECMO procedures, and extracorporeal life-support equipment limits adoption, particularly in developing regions with restricted healthcare budgets. Additionally, the need for specialized medical professionals, advanced infrastructure, and continuous monitoring during procedures creates operational challenges for healthcare facilities.

Risks associated with membrane oxygenator use, including blood clot formation, bleeding complications, infection risks, and device-related failures, may restrict market growth. Stringent regulatory requirements for medical device approvals and the complexity of developing advanced oxygenation technologies also increase manufacturing costs and slow the introduction of new products.

Growth Opportunities in the Global Membrane Oxygenators Market

The growing demand for minimally invasive cardiac procedures, advanced respiratory support, and portable extracorporeal life-support systems is creating new opportunities for membrane oxygenator manufacturers. Increasing investments in healthcare infrastructure, especially in emerging economies, along with rising adoption of ECMO therapy in specialized hospitals, are expected to expand the application scope of oxygenation technologies. Furthermore, innovations focused on compact designs, improved blood compatibility, and longer device durability can enhance clinical outcomes and encourage broader adoption.

Advancements in portable ECMO and next-generation oxygenation systems are opening opportunities for wider use beyond traditional intensive care settings. In December 2024, Johns Hopkins Medicine received more than $18 million from DARPA to develop a novel portable ECMO and advanced life-support system designed for rapid deployment, highlighting growing research interest in making extracorporeal technologies more accessible and mobile. This focus on portable and efficient life-support solutions is expected to create additional growth avenues for the membrane oxygenators market.

Key Growth Opportunities:

• Rising adoption of portable and advanced ECMO systems is creating opportunities for membrane oxygenator manufacturers to expand applications beyond traditional intensive care settings.
• Increasing healthcare investments and development of advanced critical care infrastructure in emerging economies are supporting wider access to extracorporeal life-support technologies.
• Innovation in biocompatible materials, compact oxygenator designs, and improved gas exchange technologies is creating opportunities for enhanced performance and broader clinical adoption.

Industry Trends Shaping the Global Membrane Oxygenators Market

The membrane oxygenators market is witnessing a growing shift toward intelligent, connected, and portable extracorporeal life-support technologies. Manufacturers are focusing on integrating advanced monitoring systems, improved gas management capabilities, and compact designs to enhance ECMO performance, mobility, and patient care. These advancements are supporting the broader adoption of membrane oxygenators in intensive care units, operating rooms, and transport-based critical care settings.

The increasing demand for next-generation ECMO platforms is encouraging innovation in oxygenation and extracorporeal support technologies. In March 2026, Getinge received CE mark approval for Cardiohelp II, an advanced extracorporeal life-support platform featuring enhanced monitoring capabilities, improved gas management, expanded trend analysis, and optimized blood parameter monitoring. The development reflects the industry’s focus on improving clinical decision-making, workflow efficiency, and the performance of ECMO systems that rely on advanced membrane oxygenator technologies.

Market Segments Insights:

By Product Type: The Hollow Fiber Membrane Oxygenators Segment Dominated the Global Membrane Oxygenators Market

The global membrane oxygenators market is bifurcated into product type, application, age group, end-user, and geography. On the basis of product type, the hollow fiber membrane oxygenators segment dominated market due to their superior gas exchange efficiency, compact structure, large membrane surface area, and extensive adoption in cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) procedures. These oxygenators provide efficient oxygen transfer and carbon dioxide removal while reducing blood trauma, making them the preferred choice among healthcare providers. Their advantages, including low priming volume, improved biocompatibility, and reliable performance during complex cardiac and respiratory support procedures, have contributed to their leading market position compared with flat sheet membrane oxygenators.

Continuous innovation by key market players is further strengthening the dominance of hollow fiber technology. In 2025, LivaNova PLC continued to expand its cardiopulmonary product portfolio with advanced oxygenation solutions, including the EOS ECMO Oxygenator, a plasma-tight hollow fiber oxygenator designed with polymethylpentene membrane technology and biocompatible surface treatment to support ECMO applications. These product advancements highlight the industry’s continued focus on improving oxygenator efficiency, safety, and performance, reinforcing the preference for hollow fiber membrane oxygenators in extracorporeal life-support procedures.

By Application: The Cardiopulmonary Bypass (CPB) Sub-category Holds the Largest Share of Global Membrane Oxygenators Market

On the basis of application, the global membrane oxygenators market is further segmented into cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), extracorporeal cardiopulmonary resuscitation (ECPR), respiratory support, and cardiac surgery. The cardiopulmonary bypass (CPB) segment dominates market due to its extensive application in open-heart surgeries and complex cardiovascular procedures. Membrane oxygenators are a critical component of CPB systems, enabling extracorporeal circulation by supplying oxygen and removing carbon dioxide while temporarily replacing lung function during cardiac surgery. The increasing prevalence of cardiovascular diseases, rising number of coronary artery bypass grafting (CABG), valve replacement, and congenital heart surgeries are driving the demand for CPB procedures and supporting the widespread adoption of membrane oxygenators.

Technological advancements in CPB systems are further strengthening the dominance of this segment by improving surgical efficiency, patient monitoring, and perfusion management. In August 2025, LivaNova launched the Essenz™ Perfusion System in China following regulatory approval from the National Medical Products Administration (NMPA). The advanced cardiopulmonary platform is designed to enhance data-driven perfusion management and improve workflow efficiency during cardiopulmonary bypass procedures, supporting continued innovation in cardiac surgery technologies where membrane oxygenators remain a critical component. This development highlights the ongoing modernization of CPB applications and the increasing demand for advanced membrane oxygenator systems in cardiovascular surgeries.

The Membrane Oxygenators market research report presents the analysis of each segment from 2020 to 2030 considering 2025 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2026 to 2030.

Global Membrane Oxygenators Market Segmentation:

By Product Type:

• Hollow Fiber Membrane Oxygenators
• Flat Sheet Membrane Oxygenators

By Application:

• Cardiopulmonary Bypass (CPB)
• Extracorporeal Membrane Oxygenation (ECMO)
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• Respiratory Support
• Cardiac Surgery

By Ag Group:

• Neonates
• Pediatrics
• Adults

By End-User:

• Hospitals
• Specialty Cardiac Centers
• Ambulatory Surgical Centers
• Research Institutes

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leading the Global Membrane Oxygenators Market

Geographically, the North America dominates the membrane oxygenators market due to its advanced healthcare infrastructure, high adoption of extracorporeal membrane oxygenation (ECMO) technologies, and strong presence of leading medical device manufacturers. The region has a large number of specialized cardiac hospitals, ECMO centers, and critical care facilities that utilize membrane oxygenators in cardiopulmonary bypass (CPB) and ECMO procedures. Increasing cardiovascular disease prevalence, rising demand for advanced life-support systems, favorable reimbursement policies, and significant healthcare investments are supporting the region’s leading position in the global market.

Continuous regulatory approvals and product innovations by medical device companies are further strengthening North America’s dominance. In October 2023, MC3 Inc. received U.S. FDA 510(k) clearance for the Nautilus™ VF ECMO Oxygenator, a long-term support oxygenator designed for extracorporeal life-support procedures. The FDA clearance highlights continued advancements in ECMO oxygenator technologies in the United States and supports the availability of advanced membrane oxygenation solutions for critical care applications. This development reflects ongoing innovation within the North American extracorporeal support market, where membrane oxygenators remain a key component of ECMO systems.

Competitive Analysis:

The membrane oxygenators market is characterized by the presence of established medical device companies focusing on product innovation, technological advancements, and strategic collaborations to strengthen their market position. Key players are investing in the development of advanced oxygenator technologies with improved biocompatibility, enhanced gas exchange efficiency, reduced blood trauma, and integration with next-generation extracorporeal life-support systems. Companies are also expanding their product portfolios to address the growing demand for cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) procedures worldwide.

Leading market participants such as LivaNova PLC, Getinge AB, Medtronic plc, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, and MAQUET Holding B.V. & Co. KG are focusing on new product launches, regulatory approvals, partnerships, and geographic expansion to maintain competitiveness. Recent developments in ECMO platforms, digital perfusion systems, and advanced hollow fiber membrane oxygenators are shaping the competitive landscape. The increasing demand for efficient and safer extracorporeal support technologies is encouraging companies to enhance product performance and strengthen their presence across developed and emerging healthcare markets.

Key Companies:

• LivaNova PLC
• Getinge AB
• Medtronic plc
• Terumo Corporation
• Fresenius Medical Care AG & Co. KGaA
• Braile Biomédica
• Eurosets S.r.l.
• MC3, Inc.
• Nipro Corporation
• Xenios AG

Global Membrane Oxygenators Market Outlook

• Rising adoption of ECMO and cardiopulmonary bypass procedures will drive demand for advanced membrane oxygenation technologies globally.
• Innovations in hollow fiber oxygenators, biocompatible coatings, and digital monitoring systems will improve efficiency and patient safety.
• Expanding critical care infrastructure and increasing ECMO availability will create growth opportunities across developed and emerging healthcare markets.
• Product launches, regulatory approvals, and strategic collaborations among key players will strengthen competition and accelerate market advancements.

Frequently Asked Questions About the Membrane Oxygenators Market